How Immutep Is Making Waves With Its Keytruda Combination
Immutep shares saw a nice gain in Wednesday’s session after the company released new data from its early-stage clinical trial in unresectable or metastatic melanoma patients.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 134
Hospital Launches Rehab for Cryptocurrency Traders
It was only a matter of time before cryptocurrency traders, who often sit at their trading desks for long hours at a time, attempting to reap fortunes, would need treatment for addiction.
Meet Pfizer’s Newest FDA Designations
Pfizer announced early on Monday that it received a couple critical updates from the FDA related to its Xalkori (crizotinib).
Short Interest Remains Mixed in Major Biotechs
The May 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
Major Pharma Short Sellers Grow More Selective
The May 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Why Melinta Therapeutics Shares Are Getting Crushed
Melinta Therapeutics saw its shares plunge on Thursday after the firm announced that it had priced a secondary offering.
Why Cara Therapeutics Shares Are Soaring
Cara Therapeutics shares made a solid gain on Wednesday after the firm announced that it has licensed rights to commercialize Korsuva injection for the treatment of chronic kidney disease-associated pruritus in dialysis patients.
Esperion Therapeutics Shares Briefly Halted on Late-Stage Cholesterol Trial
Esperion Therapeutics shares were halted in premarket trading on Wednesday after the firm announced late-stage trial results for its cholesterol drug.
Amgen Wins Another FDA Approval
Amgen shares made a slight gain on Tuesday after it was announced that the FDA approved its treatment of glucocorticoid-induced osteoporosis in men and women at high risk of fracture.
Dova Pharmaceuticals Slumps Despite FDA Approval
Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) shares dropped on Monday following a critical update from the U.S. Food and Drug Administration (FDA) on one of its subsidiaries. Essentially the agency granted a Priority Review for…
Should Nabriva Be Seeing a Better Response for This Positive Trial?
Nabriva Therapeutics watched its shares take a step back on Monday's despite seeing positive results in its late-stage pneumonia trial.
9 Companies Bracing for Big ASCO Reactions
This year marks the 54th annual meeting of the American Society of Clinical Oncology, the world’s largest clinical cancer conference.
FDA Lists Brand-Name Drugmakers That Obstruct Generic Development
The U.S. Food and Drug Administration on Thursday published a list of brand-name drug companies that the agency has received complaints against for obstructing development of generic versions of their drugs.
Amgen’s Novel Migraine Treatment Gets Key Approval
Amgen shares saw a nice bump after the FDA on Thursday approved its preventive treatment of migraine in adults.
Why Jounce Shares Are Crumbling Ahead of ASCO
Jounce Therapeutics watched its shares crumble on Thursday after the firm released data from its midstage cancer trial.